Latest Pharmaceutical articles

Without consent: how drugs companies exploit Indian ‘guinea pigs’

18 November 2011 -

(The Independet) By Andrew Buncombe and Nina Lakhani

Western pharmaceutical companies have seized on India over the past five years as a testing ground for drugs – making the most of a huge population and loose regulations which help dramatically cut research costs for lucrative products to be sold in the West. The relationship is so exploitative that some believe it represents a new colonialism.

Read the full article here

All CVS Locations Now Offer Disposal of Unwanted Medication

18 August 2011 -

(Environmental Leader) August 17, 2011
CVS has announced that all 7,200 of its locations now offer the Sharps Compliance Corp.’s Environmental Return System, which provides customers with the ability to safely dispose of unused medication.

read full article here

Bayer threatens to quit Germany over nuclear shutdown

8 August 2011 -

(The Guardian) By Ruby Russell
Germany’s decision to phase out nuclear power after the Fukushima catastrophe in Japan could lead to some of the country’s major companies relocating elsewhere in search of cheaper energy.

Marijn Dekkers, head of Bayer, the pharmaceuticals group, said: “It is important that we remain competitive compared with other countries. Otherwise, a global company like Bayer will have to consider relocating its production to countries with lower energy costs.”

read full article here

Pharma Sets Few Supply Chain Goals, Report Finds

8 August 2011 -

(Environmental Leader) August 4, 2011 – Pharmaceutical companies are “all over the map” in terms of their environmental goals and transparency, but largely don’t set targets for their supply chains, according to a new report.

Green Research found that major pharmaceutical companies have between five and six public environmental sustainability goals, each on average. AstraZeneca leads with 12, while Merck brings up the rear with one.

read full article here

Eli Lilly’s holistic approach to your corporate strategy

8 February 2011 -

Investing for Sustainability How adopting a holistic approach to your corporate strategy can deliver both monetary and non-monetary benefits, by Greg Spratt, advisor for environmental sustainability, Eli Lilly and Company

  • Sectors

  • Issues


  • Reference (16)
  • Archived articles: